Phase 2 deja vu for gossamer bio after ulcerative colitis med flops

cafead

Administrator
Staff member
  • cafead   Apr 25, 2022 at 10:52: PM
via Gossamer bio will end the extension of a phase 2 study for a small molecule ulcerative colitis med that was found to be ineffective—the second time in 18 months the company has seen a top program fail a midstage trial.

article source
 

<